NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Contact the NSABP

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR

To report problems, ask
questions or make comments,
please send e-mail to:

NSABP Clinical Trials Overview

Protocol C-04
A Clinical Trial to Assess the Relative Efficacy of 5-FU + Leucovorin, 5-FU + Levamisole, and 5-FU + Leucovorin + Levamisole in Patients with Dukes' B and C Carcinoma of the Colon

Specific Aims
In patients who have undergone a "curative" resection of a Dukes' B or C carcinoma of the colon, to determine if the addition of levamisole to leucovorin-modulated 5-FU provides an additional benefit in regard to disease-free survival and survival and, if so, to assess whether this benefit is superior to that achieved by administration of 5-FU + levamisole. The study will also evaluate whether 5-FU administered with levamisole is superior to leucovorin-modulated 5-FU.